Overview
Heidi Klepin is a Hematologist Oncology specialist and an Oncologist in Winston Salem, North Carolina. Dr. Klepin is rated as an Experienced provider by MediFind in the treatment of Adrenocortical Carcinoma. Her top areas of expertise are Acute Myeloid Leukemia (AML), Breast Cancer, Leukemia, and Angiosarcoma. Dr. Klepin is currently accepting new patients.
Her clinical research consists of co-authoring 196 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Medical Ctr Blvd, Winston Salem, NC 27157
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Atrium Health Levine Cancer Institute
Kunal Kadakia is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Kadakia has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Gastrointestinal Stromal Tumor, Colorectal Cancer, Glomus Jugulare Tumor, Pancreatic Cancer, and Hormone Replacement Therapy (HRT). Dr. Kadakia is currently accepting new patients.
John Powderly is a Hematologist Oncology provider in Huntersville, North Carolina. Dr. Powderly is rated as an Advanced provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), and Clear Cell Sarcoma.
Wake Forest University Health Sciences
Paul Savage is an Oncologist and a Hematologist in Winston Salem, North Carolina. Dr. Savage is rated as a Distinguished provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Bone Tumor, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Bone Marrow Aspiration, and Endoscopy. Dr. Savage is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Distinguished
- AngiosarcomaDr. Klepin isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Klepin isDistinguished. Learn about Breast Cancer.
- LeukemiaDr. Klepin isDistinguished. Learn about Leukemia.
- Paget Disease of the BreastDr. Klepin isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Inflammatory Breast CancerDr. Klepin isAdvanced. Learn about Inflammatory Breast Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Klepin isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Myelodysplastic Syndrome (MDS)Dr. Klepin isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Neuroendocrine TumorDr. Klepin isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Acute Promyelocytic LeukemiaDr. Klepin isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adrenocortical CarcinomaDr. Klepin isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Klepin isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Klepin isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Klepin isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Klepin isExperienced. Learn about Anal Cancer.